Reske-Kunz AB - Search Results

1

Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.

Klimek L, Dormann D, Jarman ER, Cromwell O, Riechelmann H, Reske-Kunz AB. Klimek L, et al. Clin Exp Allergy. 1999 Oct;29(10):1326-35. doi: 10.1046/j.1365-2222.1999.00651.x. Clin Exp Allergy. 1999. PMID: 10520053 Clinical Trial.

2

The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions.

Klimek L, Wolf H, Mewes T, Dormann D, Reske-Kunz A, Schnitker J, Mann W. Klimek L, et al. J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):47-53. doi: 10.1016/s0091-6749(99)70524-5. J Allergy Clin Immunol. 1999. PMID: 9893184 Clinical Trial.

3

Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide.

Jarman ER, Kuba A, Montermann E, Bartlett RR, Reske-Kunz AB. Jarman ER, et al. Clin Exp Immunol. 1999 Feb;115(2):221-8. doi: 10.1046/j.1365-2249.1999.00777.x. Clin Exp Immunol. 1999. PMID: 9933446 Free PMC article.

4

[Methods for monitoring of therapeutic efficacy in immunotherapy of allergic rhinitis].

Klimek L, Reske-Kunz AB, Malling HJ. Klimek L, et al. Wien Med Wochenschr. 1999;149(14-15):394-402. Wien Med Wochenschr. 1999. PMID: 10584282 Review. German.

5

Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells.

Jarman ER, Perschke K, Montermann E, Herz U, Renz H, Knop J, Reske-Kunz AB. Jarman ER, et al. J Allergy Clin Immunol. 2000 May;105(5):967-74. doi: 10.1067/mai.2000.105320. J Allergy Clin Immunol. 2000. PMID: 10808178

6

Heterogeneity in the polyclonal T cell response to birch pollen allergens.

Dormann D, Montermann E, Klimek L, Weber B, Ebner C, Valenta R, Kraft D, Reske-Kunz AB. Dormann D, et al. Int Arch Allergy Immunol. 1997 Nov;114(3):272-7. doi: 10.1159/000237679. Int Arch Allergy Immunol. 1997. PMID: 9363909

7

Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids).

Dormann D, Ebner C, Jarman ER, Montermann E, Kraft D, Reske-Kunz AB. Dormann D, et al. Clin Exp Allergy. 1998 Nov;28(11):1374-83. doi: 10.1046/j.1365-2222.1998.00407.x. Clin Exp Allergy. 1998. PMID: 9824410

8

Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity.

Weigmann B, Jarman ER, Sudowe S, Bros M, Knop J, Reske-Kunz AB. Weigmann B, et al. J Invest Dermatol. 2006 Jul;126(7):1524-33. doi: 10.1038/sj.jid.5700228. Epub 2006 Mar 16. J Invest Dermatol. 2006. PMID: 16543898 Free article.

9

[Theories on the mode of action of desensitization].

Klimek L, Reske-Kunz AB, Saloga J. Klimek L, et al. Wien Med Wochenschr. 1999;149(14-15):415-20. Wien Med Wochenschr. 1999. PMID: 10584285 Review. German.

10

Antigen dose-dependent suppression of murine IgE responses is mediated by CD4(-)CD8(-) double-negative T cells.

Barwig C, Raker V, Montermann E, Grabbe S, Reske-Kunz AB, Sudowe S. Barwig C, et al. Clin Exp Allergy. 2010 Jun;40(6):891-901. doi: 10.1111/j.1365-2222.2010.03476.x. Epub 2010 Mar 1. Clin Exp Allergy. 2010. PMID: 20214662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters